Ariela L. Marshall, M.D.

  1. Hematologist
  2. Internist
  3. Oncologist

Publications

  1. Hwa YL, Marshall AL, Shelly JL, Colborn LK, Nowakowski GS, Lacy MQ. Assessment of the Need for a Hematology-Specific Fellowship Curriculum for Advanced Practice Providers Using a Needs-Based Survey. J Oncol Pract. 2019 May 21; JOP1800697 [Epub ahead of print]
    View PubMed
  2. Marshall AL, Dasari H, Warner ND, Grill DE, Nichols WL, Pruthi RK. Self-reported reproductive health experiences in women with von Willebrand disease: a qualitative interview-based study. J Obstet Gynaecol. 2019 Feb; 39 (2):288-290 Epub 2018 Sept 12
    View PubMed
  3. Sengupta N, Marshall AL, Jones BA, Ham S, Tapper EB. Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants. Clin Gastroenterol Hepatol. 2018 Dec; 16 (12):1893-1900.e2 Epub 2018 June 30
    View PubMed
  4. Nalluru SS, Sridharan M, Go RS, Said S, Marshall AL. Shiga Toxin as a Potential Trigger of CFHR1 Deletion-Associated Thrombotic Microangiopathy. Am J Med Sci. 2018 Nov; 356 (5):492-498 Epub 2018 June 05
    View PubMed
  5. Sridharan M, Fylling KA, Ashrani AA, Chen D, Marshall AL, Hook CC, Cardel LK, Nichols WL, Pruthi RK. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience. Thromb Res. 2018 Nov; 171:14-21 Epub 2018 Sept 05
    View PubMed
  6. Marshall AL, Gupta R, Grill D, Mann S, Freidline K, Nowakowski G, Thompson C, Hobday T. Identification of Factors Associated with Hematology-Oncology Fellow Academic Success and Career Choice. J Cancer Educ. 2018 Sep 28 Epub 2018 Sept 28
    View PubMed
  7. Yeh AC, Khan MA, Harlow J, Biswas AR, Akter M, Ferdous J, Ara T, Islam M, Caron M, Barron AM, Moran J, Brezina M, Nazneen H, Kamruzzaman M, Saha A, Marshall A, Afrose S, Stowell C, Preffer F, Bangsberg D, Goodman A, Attar E, McAfee S, Spitzer TR, Dey BR. Hematopoietic Stem-Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplantation Unit in Bangladesh. J Glob Oncol. 2018 Sep; 4:1-10 Epub 2016 Dec 21
    View PubMed
  8. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 Jul; 182 (1):106-113 Epub 2018 May 16
    View PubMed
  9. Ravindran A, Go RS, Reichard KK, Marshall AL. Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center. Blood Res. 2018 Jun; 53 (2):166-167 Epub 2018 June 25
    View PubMed
  10. Goyal G, Bartley AC, Funni S, Inselman J, Shah ND, Marshall AL, Ashrani AA, Kapoor P, Durani U, Hashmi SK, Siddiqui MA, Buadi FK, Go RS, Kyle RA, Kumar S, Gonsalves WI. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia. 2018 Jun; 32 (6):1414-1420 Epub 2018 Mar 21
    View PubMed
  11. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica 2018 Apr; 103 (4):e169-e172 Epub 2017 Dec 14
    View PubMed
  12. Marshall AL, Jenkins S, Mikhael J, Gitlin SD. Determinants of hematology-oncology trainees' postfellowship career pathways with a focus on nonmalignant hematology. Blood Adv. 2018 Feb 27; 2 (4):361-369
    View PubMed
  13. Marshall AL, Jenkins S, Oxentenko AS, Lee AI, Siegel MD, Katz JT, Vyas JM, Del Valle J, Mikhael JR. Internal medicine trainees' knowledge and confidence in using the American Society of Hematology Choosing Wisely guidelines in hemostasis, thrombosis, and non-malignant hematology. PLoS One. 2018; 13 (5):e0197414 Epub 2018 May 16
    View PubMed
  14. Marshall AL, Perez Botero J, Botero JP, Ashrani AA, Pruthi RK, Heit JA, Chintakuntlawar A, Guenther JC, Patnaik MM. The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making. J Womens Health (Larchmt). 2017 Dec; 26 (12):1350-1355 Epub 2017 Sept 21
    View PubMed
  15. Marshall AL, Durani U, Bartley A, Hagen CE, Ashrani A, Rose C, Go RS, Pruthi RK. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017 Sep; 217 (3):344.e1-344.e6 Epub 2017 May 11
    View PubMed
  16. Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis. Vasc Med. 2017 Apr; 22 (2):121-127 Epub 2017 Mar 20
    View PubMed
  17. Ravindran A, Gonsalves WI, Hashmi SK, Kapoor P, Marshall AL, Siddiqui MA, Go RS. Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely? Leuk Lymphoma 2017 Jan; 58 (1):251-252 Epub 2016 June 09
    View PubMed
  18. Marshall AL, Scarpone R, De Greef M, Bird R, Kuter DJ. Remissions after long-term use of romiplostim for immune thrombocytopenia. Haematologica 2016 Dec; 101 (12):e476-e478 Epub 2016 Sept 01
    View PubMed
  19. Marshall AL, Zhang X, Lewis B, Kane S, Go RS. Sex-Based Disparities in the Use and Results of Gastrointestinal Procedures for Workup of Anemia Journal of Women’s Health, Issues & Care.2016;
  20. Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, Hashmi SK, Marshall AL, Ashrani AA, Dispenzieri A, Kyle RA, Rajkumar SV, Go RS. Prevalence, incidence and survival of smoldering multiple myeloma in the United States. Blood Cancer J 2016 Oct 21; 6 (10):e486
    View PubMed
  21. Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thome SD, Hook CC, Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clin Proc. 2016 Sep; 91 (9):1189-211 Epub 2016 Aug 03
    View PubMed
  22. Marshall AL, Levine M, Howell ML, Chang Y, Riklin E, Parry BA, Callahan RT, Okechukwu I, Ayres AM, Nahed BV, Goldstein JN. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal. J Thromb Haemost. 2016 Feb; 14: (2)324-30.
    View PubMed
  23. Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2016 Jan; 95: (1)28-37.
    View PubMed
  24. Marshall AL, Campigotto F, Neuberg D, Rowe B, Connors JM. Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin. Clin Appl Thromb Hemost. 2015 Oct; 21: (7)632-8.
    View PubMed
  25. Marshall AL, Goodarzi K, Kuter D. Romiplostim in management of the thrombocytopenic surgical patient. Transfusion. 2015; 55(10):2505-10.
    View PubMed
  26. Marshall AL, Battinelli EM, Connors JM. Decision making in venous thromboembolism. J Clin Outcomes Manag. 2015; 22(5).
  27. Marshall AL, Li A, Drucker A, Dzik W. Amniocaproic acid use in hospitalized patients with hematologic malignancy: a case series. Hematology Oncology.2015;
    View PubMed
  28. Marshall AL, Rosovsky RP. Quinine-induced thrombocytopenia in a patient with myocardial infarction. J Hematol. 2015; 4(1):137-140.
  29. Marshall AL, Connors JM. Anticoagulation for non-cardiac indications in neurological patients: comparative use of non-vitamin K oral anticoagulants, low molecular weight heparins and warfarin. Curr Treat Options Neurol. 2014; 16(9):309.
    View PubMed
  30. Marshall AL. Diagnosis, treatment and prevention of venous thromboembolism in pregnancy. Postgrad Med. 2014; 126(7):25-34.
    View PubMed
  31. Battinelli EM, Marshall AL, Connors JM. The role of thrombophilia in pregnancy. Thrombosis. 2013; 2013:516420.
    View PubMed
  32. Marshall AL, Christiani DC. Genetic variants and lung cancer risk--light at the end of the tunnel? Carcinogenesis. 2013; 34(3):487-502.
    View PubMed
  33. Renouf D, Zhai R, Sun B, Xu W, Cheung WY, Heist RS, Kulke MH, Cescon D, Asomaning K, Marshall AL, et al. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma. J Gastroenterol Hepatol. 2013; 23(9):1482-8.
    View PubMed
  34. Marshall AL, Weinstein S, Domcheck S. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging. Acad Radiol. 2012; 19(4):406-11.
    View PubMed
  35. Marshall AL, McGrath C, et al. Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient. Breast J. 2012; 18(3):272-5.
    View PubMed
  36. Cescon DW, Bradbury PA, Asomaning K, Hopkings J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Clement M, Xu W, Marshall AL, et al. p53 Arg72Pro and MDM2 T309G polymorphisms, histology and esophageal cancer prognosis. Clin Cancer Res. 2009; 15(9):3103-9.
    View PubMed
  37. Bradbury PA, Kulke MH, Heist RS, Zhou W, Ma C, Xu W, Marshall AL, et al. Cisplatin pharmacogenetics, DNA repair polymorphisms and esophageal cancer. Pharmacogenet Genomics. 2009; 19(8):613-25.
    View PubMed
  38. Bradbury PA, Heist RS, Kulke MH, Zhou W, Marshall AL, et al. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Cancer Epidemiol Biomarkers Prev. 2008; 17(1):204-11.
    View PubMed
  39. Heist RS (co-first author), Marshall AL (co-first author), et al. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. Clin Cancer Res. 2006; 12(18):5448-53.
    View PubMed
PST-20216497